Canada Ai-based Clinical Trials Solution Provider Market Size & Outlook
Canada ai-based clinical trials solution provider market, 2018-2030 (US$M)
Related Markets
Canada ai-based clinical trials solution provider market highlights
- The Canada ai-based clinical trials solution provider market generated a revenue of USD 84.4 million in 2021 and is expected to reach USD 481.8 million by 2030.
- The Canada market is expected to grow at a CAGR of 21.4% from 2022 to 2030.
- In terms of segment, oncology was the largest revenue generating therapeutic applications in 2021.
- CVD is the most lucrative therapeutic applications segment registering the fastest growth during the forecast period.
Ai-based clinical trials solution provider market data book summary
| Market revenue in 2021 | USD 84.4 million |
| Market revenue in 2030 | USD 481.8 million |
| Growth rate | 21.4% (CAGR from 2021 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | CVD |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
| Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
Other key industry trends
- In terms of revenue, Canada accounted for 6.4% of the global ai-based clinical trials solution provider market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. ai-based clinical trials solution provider market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 481.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
AI-based Clinical Trials Solution Provider Market Scope
AI-based Clinical Trials Solution Provider Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada ai-based clinical trials solution provider market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.82% in 2021. Horizon Databook has segmented the Canada ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
The AI-based clinical trials solution providers market in Canada is driven by high investments, and strategic initiatives undertaken by global as well as local players. For instance, InVivo AI, a Canadian company, partnered with Mila for development of novel algorithms for drug discovery. Such initiatives are expected to boost market growth over the forecast period.
In addition, Canada has a high number of researchers in AI domain who are responsible for increasing the adoption of technologically advanced solutions in various industries, including healthcare. For instance, according to an article published in CanadExport in 2019, there were more than 600 AI researchers in the country.
In addition, research and funding provided by the government to institutes is propelling market growth. For instance, Pan-Canadian AI Strategy, launched in 2017, plans to support research in AI and attract talent in the field to promote growth.
Reasons to subscribe to Canada ai-based clinical trials solution provider market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada ai-based clinical trials solution provider market databook
-
Our clientele includes a mix of ai-based clinical trials solution provider market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into Canada ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada artificial intelligence based clinical trials solution provider market size, by therapeutic applications, 2018-2030 (US$M)
Canada AI-based Clinical Trials Solution Provider Market Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
